Received COVID-19 Funding? How to Mitigate and Respond to Enforcement Risks and Government Actions
Jul
15
2020
Date: July 15, 2020
Time: 1:00PM - 2:00PM (EST)
Location: View the Webinar Recording
The global pandemic has caused many businesses to apply for grants and/or loans or accept and retain federal funds under the CARES Act and other federally funded relief programs. We expect civil and criminal investigations related to these COVID-19 stimulus programs to increase considerably in the coming months and years. Mintz’s COVID-19 Compliance & Enforcement Defense Task Force will review how to avoid risk and how to address enforcement when it arises.
Topics will include:
- The benefits of ongoing review of compliance with terms and conditions, attestation statements, and evolving agency guidance
- Avoiding risk in deploying, tracking, and managing funds
- Identifying and managing employee concerns or complaints
- An overview of enforcement mechanisms and enforcement actions taken to date
- Predictions regarding future enforcement activity, including whether and how enforcement may look different, depending on the outcome of the November 2020 election
- What to do if your company is subject to a government inquiry
Speakers
Karen advises industry clients on regulatory, transactional, operational, and enforcement matters. She has deep experience handling FCA investigations and qui tam litigation for laboratories and diagnostics companies.
Hope regularly defends health care companies in governmental investigations and ensuing cases, conducts internal investigations, and advises providers and manufacturers regarding enforcement issues.
Sahir Surmeli is a Mintz business counselor who advises companies, boards, entrepreneurs, investment banks, and venture and private equity investors as they build and grow companies. He handles public offerings, 144A and private financings, acquisitions, joint ventures, and strategic partnerships.